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Background: Knowing the technical characteristics of gated radiotherapy equipment is crucial for ensuring precise and
accurate treatment when using techniques such as Deep-Inspiration Breath-Hold and gating under free breathing. With
one of the first installations of the novel surface imaging system Catalyst™ (C-RAD AB, Sweden) in connection with an
Elekta Synergy linear accelerator (Elekta AB, Sweden) via the Elekta Response Interface, characteristics like dose delivery
accuracy and time delay were investigated prior to clinical implementation of gated treatments in our institution.
Methods: In this study a moving phantom was used to simulate respiratory motion which was registered by the
Catalyst™ system. The gating level was set manually. Within this gating window a trigger signal is automatically sent to
the linac initiating treatment delivery. Dose measurements of gated linac treatment beams with different gating levels
were recorded with a static 2D-Diode Array (MapCheck2, Sun Nuclear Co., USA) and compared to ungated reference
measurements for different field sizes. In addition, the time delay of gated treatment beams was measured using
radiographic film.
Results: The difference in dose delivery between gated and ungated treatment decreases with the size of the chosen
gating level. For clinically relevant gating levels of about 30%, the differences in dose delivery accuracy remain below
1%. In comparison with other system configurations in literature, the beam-on time delay shows a large deviation of
851 ms ± 100 ms.
Conclusions: When performing gated treatment, especially for free-breathing gating, factors as time delay and dose
delivery have to be evaluated regularly in terms of a quality assurance process. Once these parameters are known they
can be accounted and compensated for, e.g. by adjusting the pre-selected gating level or the internal target volume
margins and by using prediction algorithms for breathing curves. The usage of prediction algorithms becomes
inevitable with the high beam-on time delay which is reported here.
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Respiratory motion is still one of the major sources for
uncertainties in thoracic and abdominal treatment sites
in radiation therapy. The accuracy of dose delivery can
be increased by respiratory-adapted gating or breathing
control [1]. Accounting for intrafraction motion solely
by increasing the treatment margins will increase the
volume of normal tissue being irradiated with high doses* Correspondence: Philipp.Freislederer@med.uni-muenchen.de
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unless otherwise stated.[2]. Therefore techniques to minimize treatment mar-
gins are highly desirable. With the introduction of gated
treatments, in which the beam is only activated during
specific motion phases (the so-called gating window),
[3,4] the increased organ-at-risk (OAR) dose can poten-
tially be reduced to a minimum. Gated treatment has
the potential to reduce lung dose for the radiotherapy of
thoracic esophageal carcinoma using Deep-Inspiration
Breath-Hold (DIBH) techniques [5] and it is considered
reliable and effective for patients with high tumor
movements in stereotactic body radiotherapy (SBRT) [6].ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gating characteristics, including dose delivery accuracy,
overall latency, and temporal accuracy of the applied sys-
tem have to be known in advance [7]. Gating is initiated
with different respiratory monitoring systems at the mo-
ment and various studies have been performed in order to
assess the differences between them [8-11]. Several others
additionally investigated the question whether or not a
linac is able to being gated, [3] or the linac’s performance
under gated treatment [12-14].
So far the novel surface imaging system Catalyst™
(C-RAD AB, Uppsala, Sweden) in connection with an
Elekta Synergy linear accelerator (linac) with Agility Head
(Elekta AB, Stockholm, Sweden) and connectivity be-
tween those two systems via the Response™ gating inter-
face (Elekta AB, Stockholm, Sweden) has only been
examined by calculating theoretical time delays for this
system configuration [15]. Dose delivery and time delay
have already been measured for other vendors. However,
the characteristics of this specific system setup are not
known yet. Technically, the gated delivery is being per-
formed by the Response™ interface, which interrupts the
RF source during the beam-off period [16]. Our main
focus in this study is therefore not only the time delay of
the optical surface scanner for the treatment initiation,
but the overall system latency, which includes all parts
that could possibly delay beam initiation.
Methods
In this study, the gating signal used for the linac is deliv-
ered by a surface imaging system. A Dynamic ThoraxFigure 1 Left: Image of the build-up for the dynamic moving phantom
phantom as it is perceived by the Catalyst™ software.Phantom (CIRS Inc., Norfolk, VA, USA) was used to
simulate a breathing waveform, which is then measured
by the Catalyst™ system. One of the first steps of inte-
grating a system based on optical surface measurements
was to extend our movement phantom (Figure 1, left).
There was a need to construct a surface which can be
detected by the surface scanner and reproduces breath-
ing patterns imitating natural physiology. Thermoplastic
mask material was mounted to the vertical motion plat-
form of the phantom to mimic a human thorax and to
create a surface visible for the scanner.
After defining a measurement point on the phantom sur-
face, the vertical movement is recorded by the commer-
cially available Catalyst™ software. The gating level, which
in contrast to other commercially available monitoring sys-
tems is a spatial gating window in a specific millimeter
range, is set manually. Whenever the point of measurement
is detected within the gating level a trigger signal is sent
automatically to the linac, initiating treatment delivery.
Dose measurements
In order to measure possible dose differences induced
by gated treatment a 2D-Diode Array (MapCheck2, Sun
Nuclear Co., Melbourne, FL, USA) was set up stationary.
Ungated dose delivery was defined as reference and the
absolute dose of the delivery using several gating levels
was compared against this reference dose. The array was
placed isocentric in SSD = 100 cm and gating levels were
chosen as 50%, 40%, 30%, 20%, and 10% of a modulated
sine wave simulated by the moving phantom and a total
of 300 monitor units (MU) per measurement were. The surface is reconstructed using mask material. Right: The
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each gating level for two different field sizes (10 ×
10 cm2 and 20 × 20 cm2).
Time delay measurements
An extension to the existing phantom for the applica-
tion of radiographic films (Gafchromic® EBT, Inter-
national Specialty Products, Wayne, NJ, USA) was built
in order to move the film horizontally through the
gated beam (Figure 2). As the film moves through a
rectangular field with 2 cm × 2 cm field size with 6 cm
peak-to-peak amplitude (sinusoidal motion trajectory),
blackening of the film due to irradiation is expected in
a 2 cm by 5 cm rectangle (2 cm in width and height
due to the field size and an additional 3 cm in height
due to the gating window of 50% of the film move-
ment) in an ideal case of no time delay in the overall
system. The gating level was set to 50% (see Figure 3)
for sinusoidal film movements, as at this level the film
is moving with minimal acceleration and constant vel-
ocity. With a blackening of the film exceeding the ideal
(“no time delay”) blackening with a certain length (ΔL)
for beam off time delay (ΔtBEAM-OFF) and vice versa for
beam on time delay (ΔtBEAM-ON), these two measures
can by calculated for the known velocity (v) of the film
at this level by Δt = ΔL / v. Figure 3 shows the sche-
matic measurement principle. For a more detailed de-
scription of principle of the methods see Smith &
Becker [8]. The overall time delay is calculated as a
mean value from in total 6 measurements for each
beam-on and beam-off time delay. The blackening of
the film and consequently the length L was chosen as
the part where it has reached its maximum intensity,
which is equivalent to the linac reaching its maximum
dose rate.Figure 2 The custom-built extension for the film measurements.
Here the extension is placed on the moving rod of the phantom and
is moved only in the horizontal direction (red arrow).Results
Dose measurements
Measured differences in dose delivery between gated and
ungated treatment averaged over the whole field size can
be seen in Table 1. The total delivered dose decreases
with the size of the gating window. With a gating win-
dow of only 10% of the breathing cycle in a 10 × 10 cm2
field, a dose reduction of 2.15 ± 0.05% can be observed.
In addition, the treatment time for such a gating window
as narrow as 10% would be increased by a factor 10 in
comparison with ungated treatment. For a larger field
size of 20 × 20 cm2 a dose reduction of 1.62 ± 0.05% is
measured in contrast to ungated treatment. The absolute
number of start-up processes of the linac are naturally
dramatically increased when reducing the gating window
while maintaining the same amount of MUs. The rela-
tionship between dose uncertainties and the number of
start-up processes (in our case about 70–90 using a 10%
gating window and about 5–7 with a 50% gating win-
dow) becomes obvious. For larger (and therefore tem-
porally longer) gating windows which are window sizes
with more practical and clinical relevance, the differ-
ences in dose delivery accuracy decrease below 1%.
Time delay measurements
We found a value of ΔtBEAM-OFF = 215 ± 69 ms for the
system latency for beam off. For the latency of the
beam-on time, however, a value of ΔtBEAM-ON = 851 ±
100 ms has been measured, which is in contrast to
current literature, in which delays smaller than 300 ms
have been reported [16]. With the current setup for film
measurements, the relatively high standard deviation of
100 ms is explainable through measurement uncertain-
ties due to the resolution of the film, the scanning pro-
cedure, and the determination of the starting point of
ΔL. It is crucial to define the timepoint (or point on the
film respectively), that allows for a clear blackening of
the film which occurs when the linac has reached its
maximum dose rate. The dose rate varies uncontrollably
during each start-up procedure of the linac due to its
transient response, which can be seen as a reason for the
high time delay.
Discussion
The dose delivery accuracy is comparable to current lit-
erature. Evans et al. reported dosimetric differences
below 1% for beam-on times higher than 0.5 s with a
comparable linac from the same manufacturer [16]. In
our case, this beam-on-period would be comparable to a
gating window of about 30% where the difference in
dose has also been measured below 1%. Even when re-
garding different linac vendors, dosimetric differences
stay constant at around the same level, although only
larger gating windows have been evaluated [3]. A direct
Figure 3 Left: Ideal case with the absence of time delay. The blackening of the film on the bottom has the exact length of the desired
irradiation. Right: Real case with system latency: There is a difference in exposure length between the BEAM-ON signal and the actual exposure
of the film (ΔLBEAM-ON) and a difference between the termination signal of the linac and the actual termination of the beam (ΔLBEAM-OFF). Both of
these can be measured and with a given velocity, the time delay of the system (ΔtBEAM-ON and ΔtBEAM-OFF) can therefore be calculated. The
schematic blackening of the film on the bottom of each subfigure is a transposition of the film onto the time axis, as ΔL behaves linear
proportional to the time delay Δt for given velocities.
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possible, since most of these have been evaluated with
Varian linacs, [9,11] or for proton treatment sites [4].
However the data found in literature is not comparable
to the findings in this study as Varian uses a different
gating approach. For example, the BrainLAB ExacTrac
gating system (BrainLAB, Feldkirchen, Germany) in
combination with the Varian real-time position manage-
ment (RPM) gating system (Varian Medical Systems,
Palo Alto, CA, USA) were found to have a tracking time
delay for the monitoring system only of 200 ± 30 ms and
90 ± 10 ms time delay for beam-on and beam-off times
respectively, but there is no mention about the start-up
process of the linac afterwards and the subsequent dose
delivery to the patient [10].
The method for measuring the system latency has
been adapted from Smith & Becker [8]. This particular
method proves to be efficient and accurate enough in
order to measure the overall time delay. Another
method has recently been proposed by Cui et al., [15]Table 1 Results of the dose measurements for two
different field sizes: for both field sizes, there is a
decrease in dose relative to ungated treatment when
reducing the gating level and therefore increasing the
number of start-up processes and delivery time
Gating level Relative dose
(10 x 10 cm2 field)
Relative dose
(20 x 20 cm2 field)
50% 99.41 ± 0.07% 99.59 ± 0.05%
40% 99.43 ± 0.04% 99.53 ± 0.04%
30% 99.45 ± 0.52% 99.46 ± 0.04%
20% 98.81 ± 0.05% 99.09 ± 0.05%
10% 97.85 ± 0.04% 98.28 ± 0.05%which, however, does not measure the time delay for
each start-up process, does not incorporate the beam-off
delay, and the variable dose rate cannot be distinguished
in their measurements. In our measurement setup, the
time when dose rate variations occur during each start-
up process are not considered as beam-on. However the
investigators propose options for the optimization of this
issue by changing certain parameters of the linac, such
as the gun hold-on time (GHT), which is by default at a
level of 1.38 s. Increasing this parameter causes the elec-
tron gun to stay in an active state rather than switching
to standby mode. Once the electron gun reaches this
standby mode, it consequently takes longer to be in a
stabilized active mode again [15]. This is an interesting
point which is to be determined in the future at our site,
as also further dosimetric measurements have to be per-
formed. However, increasing the GHT could result in a
lower life time of the electron gun and is a setup which
has to be measured in a different way. Up to this point
only DIBH techniques are implemented at our site,
hence the lower GHT is to be considered as the regular
system setup.
Besides others, two main effects contribute to the
overall system latency, composed by the time delay of
the surrogate system (in our case the optical surface
scanner) and the time delay of the linac itself. The rather
high beam-on time delay of about 850 ms reported here
is expected to have its source primarily in the time delay
of the linac. According to Lund University [priv. comm.],
the mean time delay of the surrogate alone has been
measured with about 162 ms for beam-on time and
262 ms for beam-off time using a pneumatic piston in
order to generate the breathing pattern. They have mea-
sured the time between the output of a trigger signal
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not be performed in our site, but would be a valid way
of determining the latency of the surrogate system alone.
The beam-off delay of 262 ms for the surrogate system
alone is higher than the beam-off delay for the whole
treatment chain measured here as we were able to per-
form our measurements with a newer software version
of the surrogate system.
The difference in dose and the time delay for beam-on
are due to the fact, that every start-up process of the
linac is accompanied by a particular uncertainty because
of the linac’s transient response. The choice of the duty
cycle is crucial: With a decrease in dose of about 2% at
the 10% duty cycle and an increased treatment time,
awareness is needed when deciding on how far margins
should be reduced through gated treatment: There will
always be a trade-off between choosing a smaller gating
window to reduce margins as far as possible, which re-
duces residual geometric errors against having this smaller
gating window enhance possible dosimetric errors.
Predictive algorithms for respiratory motion imple-
mented in the software of the optical surface scanner
could potentially compensate for errors caused by time
delays. Up to this point, such algorithms can predict re-
spiratory motion up to 1000 ms [17]. Of course, the
quality of these prediction methods is still limited up to
a certain extent and larger time delays, as they have been
measured here, will also be harder to compensate for,
even with a prediction of respiratory motion. A detailed
overview of different prediction models and approaches
can be found in [18]. As interfractionally both the tumor
position and the gating window can change throughout
the course of the entire treatment, [19] a periodical up-
date for these will also be required.
Once parameters like time delay and dose distribution
are known, they have to be accounted for and compen-
sated by for example adjusting the pre-selected gating
level or the internal target volume (or also the clinical
target volume, CTV) margins.
Conclusions
When performing gated treatments, especially free-
breathing gating, it is crucial that factors such as time
delay and dose delivery accuracy have to be determined
in advance. In addition regularly QA-measurements as
proposed by the AAPM Task Group 76 [2] need to be
performed in order to assure stability over time. Our
data also indicates the need for the usage of predictive
algorithms describing the breathing curves whenever the
curves are finally used for gated treatments.
The examined system setup can and is being used for
techniques such as DIBH, where a high time delay of
about 850 ms is automatically compensated up to a cer-
tain extend due to longer gating cycles with less start-upprocesses of the linac. When it comes to free-breathing
gating, certainly some parameter changes (such as the
GHT) in the linac and the proposed prediction methods
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